184 related articles for article (PubMed ID: 31645117)
1. Combined Therapy With Dobutamine and Omecamtiv Mecarbil in Pigs With Ischemic Acute Heart Failure Is Attributed to the Effect of Dobutamine.
Rødland L; Rønning L; Kildal AB; Myrmel T; How OJ
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):232-239. PubMed ID: 31645117
[TBL] [Abstract][Full Text] [Related]
2. Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.
Bakkehaug JP; Kildal AB; Engstad ET; Boardman N; Næsheim T; Rønning L; Aasum E; Larsen TS; Myrmel T; How OJ
Circ Heart Fail; 2015 Jul; 8(4):766-75. PubMed ID: 26025342
[TBL] [Abstract][Full Text] [Related]
3. Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
Rønning L; Bakkehaug JP; Rødland L; Kildal AB; Myrmel T; How OJ
Physiol Rep; 2018 Sep; 6(19):e13879. PubMed ID: 30311442
[TBL] [Abstract][Full Text] [Related]
4. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
[TBL] [Abstract][Full Text] [Related]
5. Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
Shen YT; Malik FI; Zhao X; Depre C; Dhar SK; Abarzúa P; Morgans DJ; Vatner SF
Circ Heart Fail; 2010 Jul; 3(4):522-7. PubMed ID: 20498236
[TBL] [Abstract][Full Text] [Related]
6. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
Shen W; Gill RM; Jones BD; Zhang JP; Corbly AK; Steinberg MI
J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650
[TBL] [Abstract][Full Text] [Related]
7. Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
Teerlink JR; Felker GM; McMurray JJV; Ponikowski P; Metra M; Filippatos GS; Ezekowitz JA; Dickstein K; Cleland JGF; Kim JB; Lei L; Knusel B; Wolff AA; Malik FI; Wasserman SM;
J Am Coll Cardiol; 2016 Mar; 67(12):1444-1455. PubMed ID: 27012405
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
Shinke T; Shite J; Takaoka H; Hata K; Inoue N; Yoshikawa R; Matsumoto H; Masai H; Watanabe S; Ozawa T; Otake H; Matsumoto D; Hirata K; Yokoyama M
Am Heart J; 2007 Oct; 154(4):645.e1-8. PubMed ID: 17892985
[TBL] [Abstract][Full Text] [Related]
9. Omecamtiv Mecarbil: A Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results.
Nanasi P; Komaromi I; Gaburjakova M; Almassy J
Curr Med Chem; 2018; 25(15):1720-1728. PubMed ID: 29278207
[TBL] [Abstract][Full Text] [Related]
10. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
[TBL] [Abstract][Full Text] [Related]
11. Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure.
Liu LC; Dorhout B; van der Meer P; Teerlink JR; Voors AA
Expert Opin Investig Drugs; 2016; 25(1):117-27. PubMed ID: 26587768
[TBL] [Abstract][Full Text] [Related]
12. Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Fülöp GÁ; Oláh A; Csipo T; Kovács Á; Pórszász R; Veress R; Horváth B; Nagy L; Bódi B; Fagyas M; Helgadottir SL; Bánhegyi V; Juhász B; Bombicz M; Priksz D; Nanasi P; Merkely B; Édes I; Csanádi Z; Papp Z; Radovits T; Tóth A
Basic Res Cardiol; 2021 Apr; 116(1):24. PubMed ID: 33844095
[TBL] [Abstract][Full Text] [Related]
13. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
[TBL] [Abstract][Full Text] [Related]
14. The energy-saving effect of a new myosin activator, omecamtiv mecarbil, on LV mechanoenergetics in rat hearts with blood-perfused isovolumic contraction model.
Obata K; Morita H; Takaki M
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1065-1070. PubMed ID: 31267148
[TBL] [Abstract][Full Text] [Related]
15. Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan.
Müller S; How OJ; Jakobsen Ø; Hermansen SE; Røsner A; Stenberg TA; Myrmel T
Circ Heart Fail; 2010 Mar; 3(2):277-85. PubMed ID: 20018954
[TBL] [Abstract][Full Text] [Related]
16. Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF.
Teerlink JR; Diaz R; Felker GM; McMurray JJV; Metra M; Solomon SD; Legg JC; Büchele G; Varin C; Kurtz CE; Malik FI; Honarpour N
JACC Heart Fail; 2020 Apr; 8(4):329-340. PubMed ID: 32035892
[TBL] [Abstract][Full Text] [Related]
17. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
Abe Y; Kitada Y; Narimatsu A
J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of OPC-18790, amrinone and dobutamine on cardiac function and energy metabolism in the guinea-pig isolated ischaemic heart.
Itoh S; Mori T; Tominaga M; Ishikawa M; Koga K; Yabuuchi Y
Br J Pharmacol; 1995 Mar; 114(5):1090-6. PubMed ID: 7780644
[TBL] [Abstract][Full Text] [Related]
19. Effects of dobutamine versus insulin on cardiac performance, myocardial oxygen demand, and total body metabolism after coronary artery bypass grafting.
Hiesmayr M; Haider WJ; Grubhofer G; Heilinger D; Keznickl FP; Mares P; Rajek AM; Coraim F; Semsroth M
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):653-8. PubMed ID: 8664455
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
